Skip to main content
Clinical Trials/NCT00788632
NCT00788632
Completed
Not Applicable

Improving Care of Osteoporosis: Multi-Modal Intervention to Increase Testing and Treatment (ICOMMIITT)

University of Alabama at Birmingham2 sites in 1 country12,128 target enrollmentMay 2010
ConditionsOsteoporosis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Osteoporosis
Sponsor
University of Alabama at Birmingham
Enrollment
12128
Locations
2
Primary Endpoint
Bone Mineral Density (BMD) testing
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

The purpose of this study is to rigorously test the incremental impact of simple, generalizable interventions to improve healthcare among older women at high risk for osteoporosis. Building on the experience of our University of Alabama at Birmingham (UAB) interdisciplinary team we have designed an innovative, scientifically rigorous, and highly feasible implementation research project in partnership with two Kaiser Permanente (KP) research centers. Kaiser Permanente, one of the Nation's largest Healthcare Organizations, uses an integrated electronic medical record (EMR), with full capture of pharmacy, clinical (including BMD results), and claims data, and cares for a racially/ethnically, socio-economically, and geographically diverse population. To address innovative questions in implementation research, we will perform a multi-modal group randomized trial involving over 18,000 patients seen by over 330 primary care providers (PCPs) at 25 KP facilities in the Northwest and Southeast. If proven effective, our system-centered and patient-centered approach will advance the state of implementation science and be applicable to evidence implementation in other musculoskeletal disorders and to other health care settings.

Registry
clinicaltrials.gov
Start Date
May 2010
End Date
October 2012
Last Updated
13 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Kenneth Saag, MD, MSc

Professor of Medicine

University of Alabama at Birmingham

Eligibility Criteria

Inclusion Criteria

  • age 65 or older

Exclusion Criteria

  • prior osteoporosis testing (BMD)
  • prior osteoporosis treatment

Outcomes

Primary Outcomes

Bone Mineral Density (BMD) testing

Time Frame: 12 months

Secondary Outcomes

  • Osteoporosis prescription medications(12 months)
  • Patient-Physician communication regarding osteoporosis treatment and testing(12 months)

Study Sites (2)

Loading locations...

Similar Trials